Maculaser
PrivateLast Round
VC Round
Aug 11, 2026
Total Funding Raised
$1.44M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Maculaser operates in Healthcare & Life Sciences and is based in Espoo. Its latest recorded funding round was a VC Round in August 2026.
Maculaser is a medical technology company that develops patented, temperature-controlled retinal laser therapy designed to treat retinal diseases such as age-related macular degeneration, diabetic macular edema, and central serous chorioretinopathy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maculaser Comparables
Compare Maculaser with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OD-OS GmbH | 82% | |
| Norlase | 79% | |
| Nova Eye Medical Ltd | 76% |
For institutional investors. Book with your work email.
Maculaser Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 11, 2026 | ||||
| Seed | Feb 10, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Maculaser Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovestor | VC Round, Seed |
| M2care | VC Round |
| ZEISS Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2026
$5.08M round led by ZEISS Ventures and M2care
- Jun 18, 2026
Monthly visitors grew 216% MoM, from 116 to 366.
For institutional investors. Book with your work email.
Maculaser Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Maculaser's valuation, stock price, and market status.
Is Maculaser a public or private company?
Maculaser is a private company.
What is the current stock price of Maculaser?
Maculaser is a private company, so its shares have no public market price. Caplight tracks Maculaser's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Maculaser worth (valuation)?
Valuation information for Maculaser is not publicly available.
Can I buy Maculaser stock?
Maculaser shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Maculaser's last funding round?
Maculaser's most recent funding round was VC Round on August 11, 2026.
Who are the main investors in Maculaser?
Key investors in Maculaser include Innovestor, M2care, ZEISS Ventures.
Will Maculaser IPO soon?
No public IPO plans have been announced for Maculaser.
How can I track Maculaser secondary market activity?
Caplight tracks bids, offers, and trades in Maculaser's shares on secondary markets.